Sarver Heart Center, Departments of Medicine and Biomedical Engineering, University of Arizona, 1501 N Campbell Ave, Building 201E, Room 6139, Tucson, AZ 85724, USA.
Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY 11794, USA.
Int J Mol Sci. 2023 Apr 17;24(8):7386. doi: 10.3390/ijms24087386.
Implantable Cardiovascular Therapeutic Devices (CTD), while lifesaving, impart supraphysiologic shear stress to platelets, resulting in thrombotic and bleeding coagulopathy. We previously demonstrated that shear-mediated platelet dysfunction is associated with downregulation of platelet GPIb-IX-V and αIIbβ3 receptors via generation of Platelet-Derived MicroParticles (PDMPs). Here, we test the hypothesis that sheared PDMPs manifest phenotypical heterogeneity of morphology and receptor surface expression and modulate platelet hemostatic function. Human gel-filtered platelets were exposed to continuous shear stress. Alterations of platelet morphology were visualized using transmission electron microscopy. Surface expression of platelet receptors and PDMP generation were quantified by flow cytometry. Thrombin generation was quantified spectrophotometrically, and platelet aggregation was measured by optical aggregometry. Shear stress promotes notable alterations in platelet morphology and ejection of distinctive types of PDMPs. Shear-mediated microvesiculation is associated with the remodeling of platelet receptors, with PDMPs expressing significantly higher levels of adhesion receptors (αβ, GPIX, PECAM-1, P-selectin, and PSGL-1) and agonist receptors (PY and PAR1). Sheared PDMPs promote thrombin generation and inhibit platelet aggregation induced by collagen and ADP. Sheared PDMPs demonstrate phenotypic heterogeneity as to morphology and defined patterns of surface receptors and impose a bidirectional effect on platelet hemostatic function. PDMP heterogeneity suggests that a range of mechanisms are operative in the microvesiculation process, contributing to CTD coagulopathy and posing opportunities for therapeutic manipulation.
植入式心血管治疗装置(CTD)虽然可以救命,但会给血小板带来超生理剪切应力,导致血栓形成和出血性凝血功能障碍。我们之前的研究表明,剪切介导的血小板功能障碍与血小板 GPIb-IX-V 和 αIIbβ3 受体的下调有关,这是通过产生血小板衍生的微颗粒(PDMP)引起的。在这里,我们验证了这样一个假设,即剪切的 PDMP 表现出形态和受体表面表达的表型异质性,并调节血小板止血功能。将人凝胶过滤血小板暴露于连续剪切应力下。使用透射电子显微镜可视化血小板形态的变化。通过流式细胞术定量测定血小板受体的表面表达和 PDMP 的生成。通过分光光度法定量测定凝血酶生成,通过光学聚集法测量血小板聚集。剪切应力促进血小板形态的明显改变和独特类型的 PDMP 的释放。剪切介导的微泡形成与血小板受体的重塑有关,PDMP 表达更高水平的粘附受体(αβ、GPIX、PECAM-1、P-选择素和 PSGL-1)和激动剂受体(PY 和 PAR1)。剪切的 PDMP 促进凝血酶生成,并抑制胶原和 ADP 诱导的血小板聚集。剪切的 PDMP 在形态和定义的表面受体模式上表现出表型异质性,并对血小板止血功能产生双向影响。PDMP 的异质性表明,在微泡形成过程中存在多种机制在起作用,导致 CTD 凝血功能障碍,并为治疗干预提供机会。